5706-65-0 Usage
Description
[(4-methylphenyl)sulfonyl]carbamodithioic acid is a chemical compound with the chemical formula C9H10NO2S2. It is a carbamodithioic acid derivative, which means it contains a carbon atom double-bonded to two sulfur atoms and a nitrogen atom. The presence of a sulfonyl group and a methyl group makes this compound quite unique. It is commonly used in organic synthesis and as a reagent in various chemical reactions. Additionally, it is known for its potential pharmaceutical applications, including as a potential drug candidate due to its unique structure and properties. Overall, [(4-methylphenyl)sulfonyl]carbamodithioic acid is a versatile and important chemical compound with a wide range of applications in various fields of science and industry.
Uses
Used in Organic Synthesis:
[(4-methylphenyl)sulfonyl]carbamodithioic acid is used as a reagent in organic synthesis for its unique structure and properties, which allow it to participate in a variety of chemical reactions.
Used in Pharmaceutical Applications:
[(4-methylphenyl)sulfonyl]carbamodithioic acid is used as a potential drug candidate in the pharmaceutical industry due to its unique structure and properties, which may offer new therapeutic opportunities.
Used in Chemical Reactions:
[(4-methylphenyl)sulfonyl]carbamodithioic acid is used as a reagent in various chemical reactions, taking advantage of its unique chemical properties to facilitate specific transformations.
Check Digit Verification of cas no
The CAS Registry Mumber 5706-65-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,0 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5706-65:
(6*5)+(5*7)+(4*0)+(3*6)+(2*6)+(1*5)=100
100 % 10 = 0
So 5706-65-0 is a valid CAS Registry Number.
5706-65-0Relevant articles and documents
Novel rhenium(V) nitride complexes with dithiocarbimate ligands – A synchrotron X-ray and DFT structural investigation
Perils, Joanne,Cortezon-Tamarit, Fernando,Kuganathan, Navaratnarajah,Kociok-K?hn, Gabriele,Dilworth, Jonathan R.,Pascu, Sofia I.
, p. 142 - 149 (2017/12/11)
The application of rhenium complexes as therapeutic agents in nuclear medicine has propelled research into the chemistry of these compounds. In our effort to develop and investigate new therapeutic radiopharmaceuticals based on the complexes of rhenium we
Facile in situ copper(ii) mediated C-S bond activation transforming dithiocarbimate to carbamate and thiocarbamate generating Cu(ii) and Cu(i) complexes
Diwan, Kiran,Singh, Bandana,Singh, Santosh K.,Drew, Michael G. B.,Singh, Nanhai
supporting information; body text, p. 367 - 369 (2012/02/05)
Facile in situ Cu(ii) mediated transformation of p- tolylsulfonyldithiocarbimate in conjunction with polypyridyl or phosphine ligands into corresponding carbamate and thiocarbamate led to the formation of new copper complexes with varying nuclearities and
